{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:12:48Z","timestamp":1760955168741},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/leu.2009.197","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T09:41:16Z","timestamp":1253180476000},"page":"66-73","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR\u2013ABL1-positive acute lymphoblastic leukemia patients"],"prefix":"10.1038","volume":"24","author":[{"given":"I","family":"Iacobucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Cilloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Soverini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Paoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Chiaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vignetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Papayannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Pane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P P","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Berton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Baruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Saglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"BFleu2009197_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0889-8588(05)70198-2","volume":"15","author":"JP Radich","year":"2001","unstructured":"Radich JP . Philadelphia chromosome-positive acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001; 15: 21\u201336.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFleu2009197_CR2","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cncr.11664","volume":"98","author":"S Faderl","year":"2003","unstructured":"Faderl S, Jeha S, Kantarjian HM . The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337\u20131354.","journal-title":"Cancer"},{"key":"BFleu2009197_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110\u2013114.","journal-title":"Nature"},{"key":"BFleu2009197_CR4","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1182\/blood.V87.8.3218.bloodjournal8783218","volume":"87","author":"K Itoh","year":"1996","unstructured":"Itoh K, Friel J, Kluge N, Kina T, Kondo-Takaori A, Kawamata S et al. A novel hematopoietic multilineage clone, Myl-D-7, is stromal cell-dependent and supported by an alternative mechanism(s) independent of stem cell factor\/c-kit interaction. Blood 1996; 87: 3218\u20133228.","journal-title":"Blood"},{"key":"BFleu2009197_CR5","doi-asserted-by":"publisher","first-page":"6708","DOI":"10.1073\/pnas.0800408105","volume":"105","author":"K Paulsson","year":"2008","unstructured":"Paulsson K, Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N et al. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci USA 2008; 105: 6708\u20136713.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009197_CR6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1084\/jem.20062662","volume":"204","author":"N Feldhahn","year":"2007","unstructured":"Feldhahn N, Henke N, Melchior K, Duy C, Soh BN, Klein F et al. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J Exp Med 2007; 204: 1157\u20131166.","journal-title":"J Exp Med"},{"key":"BFleu2009197_CR7","doi-asserted-by":"publisher","first-page":"18470","DOI":"10.1074\/jbc.274.26.18470","volume":"274","author":"M Muramatsu","year":"1999","unstructured":"Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18470\u201318476.","journal-title":"J Biol Chem"},{"key":"BFleu2009197_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","volume":"20","author":"T Honjo","year":"2002","unstructured":"Honjo T, Kinoshita K, Muramatsu M . Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002; 20: 165\u2013196.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2009197_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553\u2013563.","journal-title":"Cell"},{"key":"BFleu2009197_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000; 102: 565\u2013575.","journal-title":"Cell"},{"key":"BFleu2009197_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.immunol.26.021607.090236","volume":"26","author":"JU Peled","year":"2008","unstructured":"Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF et al. The biochemistry of somatic hypermutation. Annu Rev Immunol 2008; 26: 481\u2013511.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2009197_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","volume":"76","author":"JM Di Noia","year":"2007","unstructured":"Di Noia JM, Neuberger MS . Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 2007; 76: 1\u201322.","journal-title":"Annu Rev Biochem"},{"key":"BFleu2009197_CR13","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1182\/blood-2004-04-1558","volume":"104","author":"L Pasqualucci","year":"2004","unstructured":"Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, Polakiewicz R et al. Expression of the AID protein in normal and neoplastic B cells. Blood 2004; 104: 3318\u20133325.","journal-title":"Blood"},{"key":"BFleu2009197_CR14","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1182\/blood-2002-08-2424","volume":"101","author":"J Greeve","year":"2003","unstructured":"Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574\u20133580.","journal-title":"Blood"},{"key":"BFleu2009197_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature06547","volume":"451","author":"M Liu","year":"2008","unstructured":"Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008; 451: 841\u2013845.","journal-title":"Nature"},{"key":"BFleu2009197_CR16","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1182\/blood-2003-05-1585","volume":"102","author":"E Albesiano","year":"2003","unstructured":"Albesiano E, Messmer BT, Damle RN, Allen SL, Rai KR, Chiorazzi N . Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003; 102: 3333\u20133339.","journal-title":"Blood"},{"key":"BFleu2009197_CR17","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1182\/blood-2003-05-1632","volume":"103","author":"G Babbage","year":"2004","unstructured":"Babbage G, Garand R, Robillard N, Zojer N, Stevenson FK, Sahota SS . Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood 2004; 103: 2795\u20132798.","journal-title":"Blood"},{"key":"BFleu2009197_CR18","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1182\/blood-2008-03-145995","volume":"112","author":"X Wu","year":"2008","unstructured":"Wu X, Darce JR, Chang SK, Nowakowski GS, Jelinek DF . Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells. Blood 2008; 112: 4675\u20134682.","journal-title":"Blood"},{"key":"BFleu2009197_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2007.13.2373","volume":"26","author":"F Palandri","year":"2008","unstructured":"Palandri F, Iacobucci I, Martinelli G, Amabile M, Poerio A, Testoni N et al. Long-term outcome of complete cytogenetic responders after imatinib 400\u2009mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. J Clin Oncol 2008; 26: 106\u2013111.","journal-title":"J Clin Oncol"},{"key":"BFleu2009197_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1703951","volume":"31","author":"H Esperou","year":"2003","unstructured":"Esperou H, Boiron JM, Cayuela JM, Blanchet O, Kuentz M, Jouet JP et al. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Bone Marrow Transplant 2003; 31: 909\u2013918.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2009197_CR21","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-05-2574","volume":"12","author":"I Iacobucci","year":"2006","unstructured":"Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M et al. Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. Clin Cancer Res 2006; 12: 3037\u20133042.","journal-title":"Clin Cancer Res"},{"key":"BFleu2009197_CR22","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1182\/blood-2007-09-112631","volume":"112","author":"I Iacobucci","year":"2008","unstructured":"Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E et al. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 2008; 112: 3847\u20133855.","journal-title":"Blood"},{"key":"BFleu2009197_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFleu2009197_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer B . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BFleu2009197_CR25","first-page":"37","volume":"66","author":"R Simon","year":"1982","unstructured":"Simon R, Lee Y . Nonparametric confidence limits survival probabilities and median survival time. Cancer Treat Res 1982; 66: 37\u201342.","journal-title":"Cancer Treat Res"},{"key":"BFleu2009197_CR26","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1073\/pnas.0307335101","volume":"101","author":"S Ito","year":"2004","unstructured":"Ito S, Nagaoka H, Shinkura R, Begum N, Muramatsu M, Nakata M et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci USA 2004; 101: 1975\u20131980.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009197_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.174.2.934","volume":"174","author":"X Wu","year":"2005","unstructured":"Wu X, Geraldes P, Platt JL, Cascalho M . The double-edged sword of activation-induced cytidine deaminase. J Immunol 2005; 174: 934\u2013941.","journal-title":"J Immunol"},{"key":"BFleu2009197_CR28","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.4049\/jimmunol.179.10.6783","volume":"179","author":"S Marr","year":"2007","unstructured":"Marr S, Morales H, Bottaro A, Cooper M, Flajnik M, Robert J . Localization and differential expression of activation-induced cytidine deaminase in the amphibian Xenopus upon antigen stimulation and during early development. J Immunol 2007; 179: 6783\u20136789.","journal-title":"J Immunol"},{"key":"BFleu2009197_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.molimm.2004.09.007","volume":"42","author":"M Larijani","year":"2005","unstructured":"Larijani M, Frieder D, Sonbuchner TM, Bransteitter R, Goodman MF, Bouhassira EE et al. Methylation protects cytidines from AID-mediated deamination. Mol Immunol 2005; 42: 599\u2013604.","journal-title":"Mol Immunol"},{"key":"BFleu2009197_CR30","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood-2006-10-052746","volume":"109","author":"M Vignetti","year":"2007","unstructured":"Vignetti M, Fazi P, Cimino G, Martinelli G, Di Raimondo F, Ferrara F et al. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell\u2032Adulto (GIMEMA) LAL0201-B protocol. Blood 2007; 109: 3676\u20133678.","journal-title":"Blood"},{"key":"BFleu2009197_CR31","doi-asserted-by":"crossref","first-page":"10a","DOI":"10.1182\/blood.V110.11.10.10","volume":"110","author":"R Fo\u00e0","year":"2007","unstructured":"Fo\u00e0 R, Vitale A, Meloni G, Guarini A, De Propris S, Elia L et al. Dasatinib as Front-Line Monotherapy for the Induction Treatment of Adult and Elderly Ph+ Acute Lymphoblastic Leukemia (ALL) Patients: Interim Analysis of the GIMEMA Prospective Study LAL1205. Blood 2007; 110: 10a.","journal-title":"Blood"},{"issue":"s1","key":"BFleu2009197_CR32","first-page":"367","volume":"93","author":"R Fo\u00e0","year":"2008","unstructured":"Fo\u00e0 R, Vitale A, Guarini A, De Propris MS, Elia L, Cimino G et al. Dasatinib monotherapy as 1st line treatment of Ph acute lymphoblastic leukemia (ALL) patients: update of Gimema LAL1205 study. Haematologica 2008; 93 (s1): 367.","journal-title":"Haematologica"},{"key":"BFleu2009197_CR33","doi-asserted-by":"publisher","first-page":"7352","DOI":"10.1073\/pnas.0402009101","volume":"101","author":"CL Wang","year":"2004","unstructured":"Wang CL, Harper RA, Wabl M . Genome-wide somatic hypermutation. Proc Natl Acad Sci USA 2004; 101: 7352\u20137356.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009197_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2006.01.005","volume":"21","author":"S Franco","year":"2006","unstructured":"Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA et al. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell 2006; 21: 201\u2013214.","journal-title":"Mol Cell"},{"key":"BFleu2009197_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature06638","volume":"452","author":"KM Chen","year":"2008","unstructured":"Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 2008; 452: 116\u2013119.","journal-title":"Nature"},{"key":"BFleu2009197_CR36","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1073\/pnas.0602030103","volume":"103","author":"RT Williams","year":"2006","unstructured":"Williams RT, Roussel MF, Sherr CJ . Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2006; 103: 6688\u20136693.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009197","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:17:18Z","timestamp":1648729038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFleu2009197"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.197","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]},"assertion":[{"value":"1 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}